News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,803 Results
Type
Article (2408)
Company Profile (39)
Press Release (35356)
Section
Business (14165)
Career Advice (76)
Deals (2084)
Drug Delivery (8)
Drug Development (4095)
Employer Resources (10)
FDA (428)
Job Trends (761)
News (20189)
Policy (1051)
Tag
Academia (145)
Alliances (3465)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (13)
Approvals (430)
Bankruptcy (11)
Best Places to Work (475)
Biosimilars (10)
Biotechnology (29)
Breast cancer (14)
Cancer (98)
Career advice (64)
CAR-T (10)
Cell therapy (31)
Clinical research (3133)
Collaboration (72)
Compensation (31)
COVID-19 (179)
C-suite (20)
Data (74)
Diagnostics (461)
Drug discovery (8)
Duchenne muscular dystrophy (9)
Earnings (4175)
Events (5910)
Executive appointments (67)
FDA (464)
Funding (63)
Gene editing (12)
Gene therapy (11)
GLP-1 (59)
Government (146)
Healthcare (702)
Infectious disease (182)
Inflammatory bowel disease (10)
IPO (981)
Job creations (289)
Job search strategy (62)
Layoffs (35)
Legal (210)
Lung cancer (15)
Manufacturing (16)
Medical device (313)
Medtech (313)
Mergers & acquisitions (1149)
Metabolic disorders (26)
Neuroscience (78)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (269)
Obesity (13)
Opinion (13)
Patents (13)
People (5603)
Phase I (1345)
Phase II (1575)
Phase III (838)
Pipeline (43)
Postmarket research (31)
Preclinical (582)
Radiopharmaceuticals (12)
Rare diseases (15)
Real estate (421)
Regulatory (787)
Research institute (147)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (18)
Southern California (263)
Startups (489)
United States (1287)
Vaccines (22)
Weight loss (9)
Date
Last 7 days (36)
Last 30 days (193)
Last 365 days (2561)
2025 (197)
2024 (2616)
2023 (2861)
2022 (3766)
2021 (4061)
2020 (3482)
2019 (2069)
2018 (1571)
2017 (1810)
2016 (1648)
2015 (1855)
2014 (1371)
2013 (1192)
2012 (1398)
2011 (1335)
2010 (1182)
Location
Africa (42)
Arizona (13)
Asia (1849)
Australia (296)
California (611)
Canada (113)
China (31)
Colorado (14)
Connecticut (9)
Europe (3793)
Florida (36)
Illinois (13)
Indiana (24)
Kansas (12)
Maryland (21)
Massachusetts (219)
Minnesota (14)
New Jersey (42)
New York (36)
North Carolina (79)
Northern California (269)
Ohio (22)
Pennsylvania (27)
South America (40)
Southern California (263)
Texas (50)
Washington State (33)
37,803 Results for "cogent biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cogent Biosciences to Participate in the Guggenheim Biotech Conference
January 30, 2025
·
1 min read
Press Releases
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 8, 2025
·
1 min read
Press Releases
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
January 14, 2025
·
7 min read
Business
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the appointment of Cole Pinnow as Chief Commercial Officer.
May 23, 2024
·
6 min read
Business
Cogent Biosciences Reports First Quarter 2024 Financial Results
Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, provided a business update and announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
9 min read
Press Releases
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results
November 13, 2024
·
11 min read
Press Releases
Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients
December 9, 2024
·
8 min read
Press Releases
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting
November 5, 2024
·
5 min read
Policy
Cogent Biosciences Announces Positive FDA Meeting and Alignment on MS2D2, a Novel Patient Reported Outcome Measure for the SUMMIT Trial
Cogent Biosciences, Inc. announced it has reached alignment with the U.S. Food and Drug Administration on the Company’s novel patient reported outcome measure, Mastocytosis Symptom Severity Daily Diary, for use in Part 2 of the registration-directed SUMMIT trial evaluating bezuclastinib in Nonadvanced Systemic Mastocytosis patients.
June 27, 2024
·
4 min read
Press Releases
Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
December 9, 2024
·
8 min read
1 of 3,781
Next
